Authors

• Francesco Ciompi
• Iris A.E. van der Hoorn (ORCID: https://orcid.org/0009-0008-8644-0678)
• Guus R. M. van den Heuvel (ORCID: https://orcid.org/0000-0002-5000-3213)
• Ad F. T. M. Verhagen (ORCID: https://orcid.org/0000-0003-0852-9681)
• Shoko Vos (ORCID: https://orcid.org/0000-0001-7807-3056)
• Carla M.L. van Herpen (ORCID: https://orcid.org/0000-0001-5130-5451)
• Erik H.J.G. Aarntzen (ORCID: https://orcid.org/0000-0002-3809-0182)
• Lieke L. van der Woude (ORCID: https://orcid.org/0000-0002-4761-0768)
• Sandra Heskamp (ORCID: https://orcid.org/0000-0001-7250-0846)
• I. Jolanda M. de Vries (ORCID: https://orcid.org/0000-0002-8653-4040)
• Michel M. van den Heuvel (ORCID: https://orcid.org/0000-0002-6372-2153)
• Berber Piet (ORCID: https://orcid.org/0000-0002-9069-3597)
• Evelien A. J. van Genugten (ORCID: https://orcid.org/0000-0002-7589-4294)
• Sarah R. Verhoeff (ORCID: https://orcid.org/0000-0003-4679-8938)

Institutions

• University Medical Center Groningen (NL)
• Radboud University Nijmegen (NL)
• University Medical Center (US)
• Radboud University Medical Center (NL)
• University Medical Center Utrecht (NL)
• University Hospital and Clinics (US)
• Radboud Institute for Molecular Life Sciences (NL)
• Zuyderland Medisch Centrum (NL)

Publication Details

Journal

Immunotherapy Advances

Published

2024-12-30

DOI

https://doi.org/10.1093/immadv/ltaf030

Primary Topic

Radiopharmaceutical Chemistry and Applications

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Nederlandse Organisatie voor Wetenschappelijk Onderzoek
• Radboud Institute for Health Sciences